Pfizer and BioNTech’s corona vaccine blocks 94 percent of asymptomatic infections. This is shown by research in Israel, where almost half of the population is fully vaccinated.
It has been known for some time that the corona vaccine from the American pharmaceutical giant Pfizer and the German BioNTech is efficient in preventing someone from becoming ill from the corona virus. This was evident from the clinical tests of the drug. Whether the vaccine could also prevent someone who has been vaccinated from infecting someone else was less clear until now.
Blocks 94% of asymptomatic infections
To get an answer to that question, we look at Israel. The country is leading the way when it comes to per capita vaccinations, opting fully for the Pfizer / BioNTech vaccine. Israel also agreed to collect and share real-world data on how well the vaccine works. In this way they themselves can serve as a case study for the rest of the world.
Now that almost half of the population of Israel has had two doses of the corona vaccine, the first conclusions can be drawn. It shows that the Pfizer / BioNTech vaccine blocks 94 percent of asymptomatic infections. This means that people who have been vaccinated can hardly spread the corona virus. This confirms earlier tentative conclusions from Israel. The results were measured two weeks after the second dose of the vaccine.
Pfizer itself responded enthusiastically to the findings. “These results are particularly meaningful as we try to disrupt the spread of the virus around the world,” Luis Jodar, senior vice president and chief medical officer of Pfizer’s vaccine division, said in a statement to Bloomberg.